Metraipolis › archive › dc_32ffcd6e787b
Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction-associated steatotic… — Europe PMC PMID:42368737
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42368737
- DOI
- 10.3389/fepid.2026.1779600
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:46:58.264Z
- SHA-256 of the archived text
60c407554eaa37ceac59c550c0c13b1920b89f83d5f8bb6e438bba1c4dea6747- Stable URL of this page
https://metraipolis.com/documento/dc_32ffcd6e787b
How to cite
Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction-associated steatotic… — Europe PMC PMID:42368737 — Europe PMC (en), https://europepmc.org/article/MED/42368737 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32ffcd6e787b (Metraipolis archive dc_32ffcd6e787b, sha256 60c407554eaa37ceac59c550c0c13b1920b89f83d5f8bb6e438bba1c4dea6747)
BibTeX
@misc{dc32ffcd6e787b,
title = {Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction-associated steatotic… — Europe PMC PMID:42368737},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42368737},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32ffcd6e787b; sha256 60c407554eaa37ceac59c550c0c13b1920b89f83d5f8bb6e438bba1c4dea6747},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42368737. Agents can read the archived copy with the MCP tool read_document.